IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT

被引:706
|
作者
FURITSU, T
TSUJIMURA, T
TONO, T
IKEDA, H
KITAYAMA, H
KOSHIMIZU, U
SUGAHARA, H
BUTTERFIELD, JH
ASHMAN, LK
KANAYAMA, Y
MATSUZAWA, Y
KITAMURA, Y
KANAKURA, Y
机构
[1] OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
[2] OSAKA UNIV,SCH MED,DEPT PATHOL,SUITA,OSAKA 565,JAPAN
[3] OSAKA UNIV,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN
[4] MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,ROCHESTER,MN 55905
[5] HANSON CTR CANC RES,LEUKAEMIA RES UNIT,ADELAIDE,SOUTH AFRICA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1993年 / 92卷 / 04期
关键词
PROTOONCOGENE C-KIT; POINT MUTATION; LEUKEMIA; TYROSINE KINASE; ACTIVATION;
D O I
10.1172/JCI116761
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The c-kit proto-oncogene encodes a receptor tyrosine kinase. Binding of c-kit ligand, stem cell factor (SCF) to c-kit receptor (c-kitR) is known to activate c-kitR tyrosine kinase, thereby leading to autophosphorylation of c-kitR on tyrosine and to association of c-kitR with substrates such as phosphatidylinositol 3-kinase (PI3K). In a human mast cell leukemia cell line HMC-1, c-kitR was found to be constitutively phosphorylated on tyrosine, activated, and associated with PI3K without the addition of SCF. The expression of SCF mRNA transcript in HMC-1 cells was not detectable by means of PCR after reverse transcription (RT-PCR) analysis, suggesting that the constitutive activation of c-kitR was ligand independent. Sequencing of whole coding region of c-kit cDNA revealed that c-kit genes of HMC-1 cells were composed of a normal, wild-type allele and a mutant allele with two point mutations resulting in intracellular amino acid substitutions of Gly-560 for Val and Val-816 for Asp. Amino acid sequences in the regions of the two mutations are completely conserved in all of mouse, rat, and human c-kit. In order to determine the causal role of these mutations in the constitutive activation, murine c-kit mutants encoding Gly-559 and/or Val-814, corresponding to human Gly-560 and/or Val-816, were constructed by site-directed mutagenesis and expressed in a human embryonic kidney cell line, 293T cells. In the transfected cells, both c-kitR (Gly-559, Val-814) and c-kitR (Val-814) were abundantly phosphorylated on tyrosine and activated in immune complex kinase reaction in the absence of SCF, whereas tyrosine phosphorylation and activation of c-kitR (Gly-559) or wild-type c-kitR was modest or little, respectively. These results suggest that conversion of Asp-816 to Val in human c-kitR may be an activating mutation and responsible for the constitutive activation of c-kitR in HMC-1 cells.
引用
收藏
页码:1736 / 1744
页数:9
相关论文
共 50 条
  • [41] MAST-CELL NUMBER IN THE SKIN OF HETEROZYGOTES REFLECTS THE MOLECULAR NATURE OF C-KIT MUTATION
    TSUJIMURA, T
    KOSHIMIZU, U
    KATOH, H
    ISOZAKI, K
    KANAKURA, Y
    TONO, T
    ADACHI, S
    KASUGAI, T
    TEI, H
    NISHIMUNE, Y
    NOMURA, S
    KITAMURA, Y
    BLOOD, 1993, 81 (10) : 2530 - 2538
  • [42] MUTATION OF THE C-KIT (MAST STEM-CELL GROWTH-FACTOR RECEPTOR) PROTOONCOGENE IN HUMAN PIEBALDISM
    SPRITZ, RA
    GIEBEL, LB
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 38 - 38
  • [43] A FORM OF C-KIT LIGAND WITH ENHANCED GROWTH-FACTOR ACTIVITY BUT NOT ENHANCED MAST-CELL DEGRANULATION ACTIVITY
    LOBELL, R
    KO, J
    LEVINE, B
    LANDGRAF, B
    NAIR, N
    SMITH, E
    BURCH, P
    SEGAL, R
    FISHER, R
    NOCKA, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 292 - 292
  • [44] C-kit mutations and mast cell disorders - A model of activating mutations of growth factor receptors
    Pignon, JM
    HEMATOLOGY AND CELL THERAPY, 1997, 39 (02): : 114 - 116
  • [45] MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) RESTORES GROWTH OF MULTIPOTENT PROGENITORS IN MYELODYSPLASTIC SYNDROME
    GLINSMANNGIBSON, B
    SPIER, C
    BAIER, M
    TAETLE, R
    BROUDY, VC
    LIST, AF
    LEUKEMIA, 1994, 8 (05) : 827 - 832
  • [46] HUMAN STEM-CELL FACTOR (C-KIT LIGAND) INDUCES AN AUTOCRINE LOOP OF GROWTH IN GM-CSF-DEPENDENT MEGAKARYOCYTIC LEUKEMIA-CELL LINE
    KISS, C
    CESANO, A
    ZSEBO, KM
    CLARK, SC
    SANTOLI, D
    LEUKEMIA, 1993, 7 (02) : 235 - 240
  • [47] Identical novel C-KIT transcripts in two patients with mast cell leukemia.
    Ozer, O
    Anastasi, J
    Vardiman, JW
    Godley, LA
    BLOOD, 2004, 104 (11) : 552A - 552A
  • [48] LIGAND-INDEPENDENT ACTIVATION OF C-KIT RECEPTOR TYROSINE KINASE IN A MURINE MASTOCYTOMA CELL-LINE P-815 GENERATED BY A POINT MUTATION
    TSUJIMURA, T
    FURITSU, T
    MORIMOTO, M
    ISOZAKI, K
    NOMURA, S
    MATSUZAWA, Y
    KITAMURA, Y
    KANAKURA, Y
    BLOOD, 1994, 83 (09) : 2619 - 2626
  • [49] Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: Selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture
    Morita, S
    Tsuchiya, S
    Fujie, H
    Itano, M
    Ohashi, Y
    Minegishi, M
    Imaizumi, M
    Endo, M
    Takano, N
    Konno, T
    LEUKEMIA, 1996, 10 (01) : 102 - 105
  • [50] In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent c-kit mutation
    Beghini, A
    Cairoli, R
    Morra, E
    Larizza, L
    BLOOD CELLS MOLECULES AND DISEASES, 1998, 24 (12) : 262 - 270